{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:38:07Z","timestamp":1790116687326,"version":"4.0.1"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Inflammatory bowel disease (IBD) is a chronic relapsing gastrointestinal disorder with a high symptom burden. Patients often report multiple concurrent symptoms, yet most studies have examined them individually. Symptom clusters\u2014defined as groups of co-occurring and interrelated symptoms\u2014provide a framework for understanding this complexity. Evidence on IBD-specific clusters, however, remains fragmented and inconsistent.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a scoping review following Arksey and O'Malley's framework to synthesize findings on IBD symptom cluster types, assessment instruments, associated factors, and dynamic trajectories. Searches covered database inception through 31 October 2024.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirteen studies were included, identifying 29 symptom clusters. Marked heterogeneity and overlap were observed. To integrate findings, clusters were categorized into five groups: gastrointestinal\/physical, psychological, systemic\/fatigue, nutritional\/appetite-related, and mixed\/trajectory-related. Assessment instruments varied considerably, most lacking IBD-specific validation. Reported associated factors included demographic, clinical, and treatment variables, but results were inconsistent. Few studies addressed longitudinal changes or interactions among clusters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Research on IBD symptom clusters remains limited and heterogeneous. Standardized definitions and validated tools are urgently needed. Most existing studies did not stratify findings by disease subtype, although limited evidence indicates that UC and CD appear to exhibit distinct clustering patterns. Future studies should adopt longitudinal and biomarker-informed designs, and examine interactions among clusters, to improve clinical management and patient outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1615100","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:27Z","timestamp":1758000927000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Symptom clusters in inflammatory bowel disease: a scoping review"],"prefix":"10.3389","volume":"12","author":[{"given":"Keying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut."},{"key":"B2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","article-title":"Multiomics to elucidate inflammatory bowel disease risk factors and pathways","volume":"19","author":"Agrawal","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ueg2.12319","article-title":"Environmental risk factors for inflammatory bowel disease","volume":"10","author":"Singh","year":"2022","journal-title":"United Eur Gastroenterol J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/CM9.0000000000003542","article-title":"Epidemiology, pathogenesis, diagnosis, and treatment of inflammatory bowel disease: Insights from the past two years","volume":"138","author":"Wan","year":"2025","journal-title":"Chinese Med J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S2468-1253(19)30013-5","article-title":"Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development","volume":"4","author":"King","year":"2019","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e41840","DOI":"10.1016\/j.heliyon.2025.e41840","article-title":"Clinical epidemiology of inflammatory bowel disease among adults in the South Asian region: a systematic review and meta-analysis","volume":"11","author":"Niriella","year":"2025","journal-title":"Heliyon."},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","year":"2020","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"103655","DOI":"10.1016\/j.autrev.2024.103655","article-title":"Analysis of global prevalence, DALY and trends of inflammatory bowel disease and their correlations with sociodemographic index: data from 1990 to 2019","volume":"23","author":"Dou","year":"2024","journal-title":"Autoimmun Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"5751","DOI":"10.3748\/wjg.v29.i42.5751","article-title":"Global burden of inflammatory bowel disease 1990-2019: a systematic examination of the disease burden and twenty-year forecast","volume":"29","author":"Li","year":"2023","journal-title":"World J Gastroenterol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.dld.2023.04.003","article-title":"The global, regional, and national burden of inflammatory bowel diseases, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"55","author":"Park","year":"2023","journal-title":"Digest Liver Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"103498","DOI":"10.1016\/j.autrev.2023.103498","article-title":"Global, regional, and national burden of inflammatory bowel disease and its associated anemia, 1990 to 2019 and predictions to 2050: An analysis of the global burden of disease study 2019","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000511481","article-title":"Approach to the seamless management of inflammatory bowel disease, considering special situations, shared decision-making, and disease burden","volume":"102","author":"Aoyama","year":"2021","journal-title":"Digestion."},{"key":"B14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12876-020-01526-2","article-title":"Correction to: Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort [Published Erratum]","volume":"20","author":"Perler","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/jcm13041019","article-title":"Prevalence and clinical impact of immune-mediated inflammatory diseases in patients with inflammatory bowel disease: results from a large retrospective observational study","volume":"13","author":"Vernero","year":"2024","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1046\/j.1365-2648.2001.01697.x","article-title":"Advancing the science of symptom management","volume":"33","author":"Dodd","year":"2001","journal-title":"J Adv Nurs."},{"key":"B17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00002820-200507000-00005","article-title":"Symptom clusters: concept analysis and clinical implications for cancer nursing","volume":"28","author":"Kim","year":"2005","journal-title":"Cancer Nurs"},{"key":"B18","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/nur.21813","article-title":"Symptom clusters in adults with inflammatory bowel disease","volume":"40","author":"Conley","year":"2017","journal-title":"Res Nurs Health."},{"key":"B19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1440-172X.2010.01867.x","article-title":"Symptom burden in inflammatory bowel disease: rethinking conceptual and theoretical underpinnings","volume":"16","author":"Farrell","year":"2010","journal-title":"Int J Nurs Pract."},{"key":"B20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1440-172X.2012.02063.x","article-title":"Symptom burden: a forgotten area of measurement in inflammatory bowel disease","volume":"18","author":"Farrell","year":"2012","journal-title":"Int J Nurs Pract."},{"key":"B21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol."},{"key":"B22","volume-title":"The symptom experience of newly diagnosed patients with Crohn's disease: a longitudinal qualitative research","author":"Chen","year":"2022"},{"key":"B23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/jnu.12409","article-title":"Longitudinal changes in symptom cluster membership in inflammatory bowel disease","volume":"50","author":"Conley","year":"2018","journal-title":"J Nurs Scholarsh."},{"key":"B24","unstructured":"Gu\n              F\n            \n          \n          Nanjing Medical University\n          Compilation and preliminary application of Symptom Cluster Scale for Inflammatory Bowel Disease\n          \n          2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3761\/j.issn.0254-1769.2020.12.004","article-title":"Construction and preliminary application of Symptom Cluster Scale for inflammatory bowel disease","volume":"55","author":"Gu","year":"2020","journal-title":"Chin J Nurs."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3761\/j.issn.0254-1769.2021.14.005","article-title":"Study on symptom cluster and its influencing factors in patients with ulcerative colitis","volume":"36","author":"Guan","year":"2021","journal-title":"J Nurses Prof Dev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12876-023-02889-y","article-title":"Symptoms and symptom clusters in patients newly diagnosed with inflammatory bowel disease: results from the IBSEN III Study","volume":"23","author":"Johansen","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s42976-021-00214-5","article-title":"Analysis of correlations between disease symptom clusters and quality of survival and psychological factors in patients with inflammatory bowel disease","volume":"27","author":"Liu","year":"2022","journal-title":"China J Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12876-019-0963-7","article-title":"Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort","volume":"19","author":"Perler","year":"2019","journal-title":"BMC Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1111\/apt.17735","article-title":"Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study","volume":"58","author":"Riggott","year":"2023","journal-title":"Aliment Pharmacol Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1093\/ibd\/izz038","article-title":"The inflammatory bowel disease symptom inventory: a patient-report scale for research and clinical application","volume":"25","author":"Sexton","year":"2019","journal-title":"Inflamm Bowel Dis."},{"key":"B32","first-page":"1538","article-title":"Application value analysis of symptom cluster assessment scale in patients with inflammatory bowel disease","volume":"8","author":"Xu","year":"2022","journal-title":"Chin Evid Based Nurs."},{"key":"B33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/SGA.0000000000000793","article-title":"Illness perceptions as a predictor of symptom cluster trajectories in patients with inflammatory bowel disease: a latent growth mixture model","volume":"47","author":"Zhijia","year":"2024","journal-title":"Gastroenterol Nurs."},{"key":"B34","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1586\/17474124.2015.1038241","article-title":"Symptom management in inflammatory bowel disease","volume":"9","author":"Abraham","year":"2015","journal-title":"Exp Rev Gastroenterol Hepatol."},{"key":"B35","first-page":"1","article-title":"Expert consensus on nursing care for adults with active inflammatory bowel disease","volume":"37","author":"Zhu","year":"2022","journal-title":"J Nurs Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1631207","DOI":"10.3389\/fmed.2025.1631207","article-title":"Exploring the multidimensional symptom experience in patients with inflammatory bowel disease\u2014a contemporaneous network analysis","volume":"12","author":"Di","year":"2025","journal-title":"Front Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/ajg.2014.237","article-title":"Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales","volume":"109","author":"Spiegel","year":"2014","journal-title":"Am. J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.cgh.2017.10.019","article-title":"Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review","volume":"16","author":"de Jong","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.14309\/01.ajg.0000995756.95860.25","article-title":"S5 understanding gastrointestinal symptoms in patients with concomitant irritable bowel syndrome and inflammatory bowel disease: a cross-sectional study from IBD partners","volume":"118","author":"Gracey","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/0959-8049(94)90182-1","article-title":"The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress","author":"Portenoy","year":"1994","journal-title":"Eur J Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/apt.17241","article-title":"Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with IBD (the Manitoba Living with IBD study)","volume":"56","author":"Kulyk","year":"2022","journal-title":"Aliment Pharmacol Ther."},{"key":"B42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1136\/flgastro-2023-102523","article-title":"Optimising triage of urgent referrals for suspected IBD: results from the Birmingham IBD inception study","volume":"15","author":"Rimmer","year":"2024","journal-title":"Frontline Gastroenterol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e41120","DOI":"10.7759\/cureus.41120","article-title":"Advancements in inflammatory bowel disease: a narrative review of diagnostics, management, epidemiology, prevalence, patient outcomes, quality of life, and clinical presentation","volume":"15","author":"Muzammil","year":"2023","journal-title":"Cureus J Med Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41575-022-00634-6","article-title":"Depression and anxiety in inflammatory bowel disease: epidemiology mechanisms and treatment","volume":"19","author":"Bisgaard","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/ibd\/izae151","article-title":"Consensus statement on managing anxiety and depression in individuals with inflammatory bowel disease","volume":"31","author":"Hinnant","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"714057","DOI":"10.3389\/fpsyt.2021.714057","article-title":"Depression and anxiety disorders in patients with inflammatory bowel disease","volume":"12","author":"Hu","year":"2021","journal-title":"Front Psychiatry."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e72324","DOI":"10.7759\/cureus.72324","article-title":"Advancements in the management of pediatric and adult inflammatory bowel disease: a systematic review of treatment strategies and long-term outcomes","volume":"16","author":"Adedara","year":"2024","journal-title":"Cureus J Med Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41575-024-01035-7","article-title":"Understanding the therapeutic toolkit for inflammatory bowel disease","volume":"22","author":"Vieujean","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1615100\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:35:30Z","timestamp":1758000930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1615100\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":49,"alternative-id":["10.3389\/fmed.2025.1615100"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1615100","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"article-number":"1615100"}}